Spyre Therapeutics, Inc. SYRE Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s change in other assets?
- Spyre Therapeutics, Inc. (SYRE) reported change in other assets of $233K in Q1 2026.
- How has Spyre Therapeutics, Inc.'s change in other assets changed year-over-year?
- Spyre Therapeutics, Inc.'s change in other assets increased by 150.4% year-over-year, from -$462K to $233K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.